Wall Street Zen Upgrades Oscar Health (NYSE:OSCR) to “Hold”

Oscar Health (NYSE:OSCR) was upgraded by stock analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday.

Several other research firms have also recently issued reports on OSCR. Stephens assumed coverage on Oscar Health in a research report on Thursday, December 11th. They set an “equal weight” rating and a $17.00 price objective for the company. Raymond James Financial raised Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price target for the company in a report on Thursday. UBS Group reiterated a “neutral” rating and issued a $15.00 price target on shares of Oscar Health in a research note on Wednesday. Barclays set a $18.00 price objective on shares of Oscar Health and gave the stock an “equal weight” rating in a report on Monday, January 5th. Finally, Piper Sandler upgraded shares of Oscar Health from a “neutral” rating to an “overweight” rating and upped their target price for the company from $13.00 to $25.00 in a report on Tuesday, November 25th. Two analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $16.88.

Oscar Health Price Performance

Shares of OSCR opened at $13.41 on Friday. The firm has a market capitalization of $3.55 billion, a price-to-earnings ratio of -7.70 and a beta of 1.90. The firm’s fifty day simple moving average is $15.24 and its 200-day simple moving average is $16.69. Oscar Health has a twelve month low of $11.20 and a twelve month high of $23.80. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67.

Oscar Health (NYSE:OSCR) last issued its earnings results on Tuesday, February 10th. The company reported ($1.24) EPS for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.32). Oscar Health had a negative return on equity of 37.72% and a negative net margin of 3.79%.The firm had revenue of $2.76 billion for the quarter, compared to analyst estimates of $3.12 billion. During the same quarter in the previous year, the firm posted ($0.62) EPS. The business’s revenue for the quarter was up 17.3% on a year-over-year basis. Equities analysts forecast that Oscar Health will post 0.69 EPS for the current fiscal year.

Insider Transactions at Oscar Health

In related news, insider Mario Schlosser sold 23,038 shares of the stock in a transaction on Thursday, January 8th. The shares were sold at an average price of $17.65, for a total transaction of $406,620.70. Following the completion of the sale, the insider owned 350,180 shares in the company, valued at $6,180,677. This represents a 6.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Adam Mcananey sold 1,852 shares of the firm’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $30,724.68. Following the transaction, the insider directly owned 179,241 shares in the company, valued at $2,973,608.19. The trade was a 1.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 197,125 shares of company stock valued at $3,265,300 over the last ninety days. 24.39% of the stock is owned by insiders.

Institutional Investors Weigh In On Oscar Health

Hedge funds have recently made changes to their positions in the business. Envestnet Asset Management Inc. grew its stake in shares of Oscar Health by 200.9% in the 2nd quarter. Envestnet Asset Management Inc. now owns 30,210 shares of the company’s stock valued at $648,000 after purchasing an additional 20,171 shares during the last quarter. Udine Wealth Management Inc. raised its stake in shares of Oscar Health by 138.4% during the third quarter. Udine Wealth Management Inc. now owns 146,555 shares of the company’s stock worth $2,774,000 after purchasing an additional 85,083 shares during the last quarter. Lane Generational LLC acquired a new stake in shares of Oscar Health during the second quarter worth $4,800,000. Q Fund Management Hong Kong Ltd purchased a new position in Oscar Health in the 3rd quarter valued at $5,940,000. Finally, Jump Financial LLC grew its position in Oscar Health by 798.3% in the 2nd quarter. Jump Financial LLC now owns 1,441,506 shares of the company’s stock valued at $30,906,000 after buying an additional 1,281,032 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.